Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo

Clinical Immunology and Immunopathology

Volumn 53, Issue 3, 1989, Pages 488-498

  Shalaby, M R ^a   Waage, A ^a   Aarden, L ^b,c   Espevik, T ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b CENTRAL LABORATORY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; DRUG COMBINATION; DRUG COMPARISON; HYPOTHERMIA; MOUSE; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL;

ANIMAL; ENDOTOXINS; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; RECOMBINANT PROTEINS; SHOCK, SEPTIC; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR NECROSIS FACTOR;

EID: 0024357546     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-1229(89)90010-X     Document Type: Article

References (28)

1. 2, HPGF)
2. A new interleukin with pleiotropic activities
3. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells
4. Molecular cloning and expression of hybridoma growth factor in Escherichia coli
5. 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells
6. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
7. Synergistic activation of human T cells by interleukin 1 and interleukin 6
8. Interleukin 6 is involved in interleukin 1-induced activities
9. Interleukin-6 in synovial fluid from patients with arthritis
10. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
11. The complex pattern of cytokines in serum from patients with meningococcal septic shock
12. Elevated levels of the 26 K human hybridoma growth factor (interleukin-6) in cerebrospinal fluid of patients with acute infection of the central nervous system
13. Interleukin 6 (IL-6) in serum and urine of renal transplants recipients
14. Purification and characterization of human interleukin-1 expressed in recombinant Escherichia coli
15. Cloning and expression in E. coli of the cDNA for murine tumor necrosis factor
16. Production of hybridoma growth factor by human monocytes
17. Serum-free in vitro bioassay for the detection of tumor necrosis factor
18. Interleukin 1 potentiates the lethal effect of tumor necrosis factor/cachectin in mice
19. A highly sensitive cell line, WEHI 164, clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
20. Cytokine regulation of interleukin 6 production by human endothelial cells
21. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors
22. IL-6/IFN-γ-2 as a circulating hormone: Induction by cytokine administration in humans
23. Tumor necrosis factor and interleukin-1: Role in acute inflammation and microvascular injury
24. The biology of interleukin 1 and comparison to tumor necrosis factor
25. Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor
26. Pharmacolinetics of murine tumor necrosis factor
27. Acute inflammation and Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor: Synergistic action of the cytokines in the induction of inflammation and microvascular injury
28. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor